BioSpace News Archive

Policy

FDA Issues Guidance to Assess Benefit-Risk of Opioids Prior to Approval

The regulatory agency is establishing new standards for the approval of opioid medications.

June 21, 2019
·
2 min read
·
Alex Keown
Deals

Six Biotech Companies with IPOs This Week

This week marked initial public offering news from six biopharma companies. Here’s a look.

June 21, 2019
·
3 min read
·
Mark Terry
Policy

Trump Expected to Issue Executive Order in Attempt to Lower Health Care Costs

The order would compel healthcare providers, such as hospitals, to disclose information about negotiated and discounted costs of care.

June 21, 2019
·
3 min read
·
Alex Keown
Drug Development

Clinical Catch-Up for June 17-21

Plenty of biopharma companies released results from clinical trials last week. Here’s a look at the top stories.

June 21, 2019
·
4 min read
·
Mark Terry
FDA

FDA Action Alert: Regeneron, Sanofi, Celgene

July looks to be a quiet month for the U.S. Food and Drug Administration (FDA), and it sure looks like the agency is trying to get a lot of work done before the July 4 holiday. Here’s a look at the many approvals scheduled for this week.

June 21, 2019
·
4 min read
·
Mark Terry